CV004-007 Thrombosis Chamber Study
NCT02439190 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2016-09-08
Summary
The purpose of this study is to determine whether BMS-986120, aspirin, or aspirin and clopidogrel decrease blood clotting.
Conditions
Interventions
- DRUG
-
BMS-986120
- DRUG
- DRUG
-
Clopidogrel
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2016-03-31
- Completion
- 2016-03-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants
NCT03341390 ·Status: COMPLETED ·Phase: PHASE1
-
Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke
NCT00240643 ·Status: COMPLETED ·Phase: PHASE2
-
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
NCT02144831 ·Status: WITHDRAWN ·Phase: PHASE4
-
Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty
NCT00289601 ·Status: TERMINATED ·Phase: PHASE4
-
Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin
NCT03424408 ·Status: COMPLETED ·Phase: NA
-
Comparative Effects of Aspirin and NHP-544C
NCT02189122 ·Status: COMPLETED ·Phase: NA
-
PPARGC1β and CNTN4 Genotype Aspirin Study
NCT02970604 ·Status: UNKNOWN ·Phase: PHASE4
-
Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events
NCT01924325 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their Effects
NCT01409616 ·Status: COMPLETED ·Phase: PHASE1
-
Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II
NCT04078737 ·Status: COMPLETED ·Phase: PHASE3
-
High-Shear Microfluidic Thrombosis Assay
NCT02422810 ·Status: COMPLETED
-
Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate
NCT02243137 ·Status: COMPLETED ·Phase: PHASE1
-
Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration
NCT00748371 ·Status: TERMINATED ·Phase: PHASE4
-
COMT on Aspirin Platelets Effects (CAPE)
NCT03433586 ·Status: UNKNOWN ·Phase: PHASE4
-
Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
NCT05515120 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
NCT04498273 ·Status: TERMINATED ·Phase: PHASE3
-
To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects
NCT01424332 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction Study Between AZD3480 and Warfarin
NCT00689637 ·Status: COMPLETED ·Phase: PHASE1
-
Recurrent Carotid Stenosis
NCT00000527 ·Status: COMPLETED ·Phase: PHASE2
-
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
NCT01938248 ·Status: COMPLETED ·Phase: PHASE4
-
TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular Disease
NCT04132791 ·Status: TERMINATED ·Phase: NA
-
Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin Therapy
NCT04059679 ·Status: UNKNOWN ·Phase: PHASE4
-
Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection
NCT00265408 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers
NCT02268773 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin and Clopidogrel Resistance Study
NCT01039480 ·Status: COMPLETED